Successful long-term use of pioglitazone in Berardinelli–Seip lipodystrophy-associated diabetes
Berardinelli–Seip congenital lipodystrophy (BSCL) is a rare autosomal recessive disease, characterized by the absence of subcutaneous adipose tissue, leptin deficiency and severe metabolic complications, such as insulin resistance, diabetes mellitus, and dyslipidemia. The most common mutation occurs...
Main Authors: | Carolina Chaves, Mariana Chaves, João Anselmo, Rui César |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2021-04-01
|
Series: | Endocrinology, Diabetes & Metabolism Case Reports |
Online Access: | https://edm.bioscientifica.com/view/journals/edm/2021/1/EDM20-0183.xml |
Similar Items
-
Berardinelli-Seip congenital lipodystrophy in two siblings
by: T Rao, et al.
Published: (2014-01-01) -
Nurses' knowledge about Berardinelli-Seip Congenital Lipodystrophy.
by: Verônica Kristina Cândido Dantas, et al.
Published: (2018-01-01) -
Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy.
by: Josivan Gomes Lima, et al.
Published: (2018-01-01) -
Cardiac involvement in total generalized lipodystrophy (Berardinelli- Seip syndrome)
by: Viégas Ruy Felipe Melo, et al.
Published: (2000-01-01) -
Impairment of respiratory muscle strength in Berardinelli-Seip congenital lipodystrophy subjects
by: Jorge Luiz Dantas de Medeiros, et al.
Published: (2018-09-01)